INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kips Bay Select LP(9.92%)
INNOVATION PHARMACEUTICALS INC | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
INNOVATION PHARMACEUTICALS INC | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
INNOVATION PHARMACEUTICALS INC | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
INNOVATION PHARMACEUTICALS INC | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)